BridgeBio Pharma, Inc. (BBIO): 8-K filed Aug 31, 2026

Form type

8-K

Filing date

Aug 31, 2026

Accession number

0001140361-26-035055

Filer

BridgeBio Pharma, Inc. (CIK 1743881)